279 related articles for article (PubMed ID: 35926375)
41. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
[TBL] [Abstract][Full Text] [Related]
42. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
43. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis.
Makki RF; al Sharif F; González-Gay MA; García-Porrúa C; Ollier WE; Hajeer AH
Clin Exp Rheumatol; 2000; 18(3):391-3. PubMed ID: 10895380
[TBL] [Abstract][Full Text] [Related]
44. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
[TBL] [Abstract][Full Text] [Related]
45. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
46. The Spectrum of Pericardial Involvement in Giant Cell Arteritis and Polymyalgia Rheumatica: A Systematic Review of Literature.
Fayyaz B; Rehman HJ
J Clin Rheumatol; 2021 Jan; 27(1):5-10. PubMed ID: 31483352
[TBL] [Abstract][Full Text] [Related]
47. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
48. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
49. Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
van Sleen Y; Therkildsen P; Nielsen BD; van der Geest KSM; Hansen I; Heeringa P; Posthumus MD; Sandovici M; Toonen EJM; Zijlstra J; Boots AMH; Hauge EM; Brouwer E
Arthritis Res Ther; 2022 Mar; 24(1):65. PubMed ID: 35255968
[TBL] [Abstract][Full Text] [Related]
50. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis.
Manzo C; Maslinska M; Castagna A; Hysa E; Merante A; Milchert M; Gravina T; Sargin B; Natale M; Ruberto C; Ruotolo G
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917502
[No Abstract] [Full Text] [Related]
51. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.
Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T
Semin Arthritis Rheum; 2022 Aug; 55():152017. PubMed ID: 35537222
[TBL] [Abstract][Full Text] [Related]
52. Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica.
Milchert M; Brzosko M
Rheumatol Int; 2020 Dec; 40(12):2071-2075. PubMed ID: 32683496
[TBL] [Abstract][Full Text] [Related]
53. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
[TBL] [Abstract][Full Text] [Related]
55. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
Gonzalez-Gay MA
Semin Arthritis Rheum; 2004 Apr; 33(5):289-93. PubMed ID: 15079759
[TBL] [Abstract][Full Text] [Related]
56. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
Sharma A; Mohammad AJ; Turesson C
Semin Arthritis Rheum; 2020 Oct; 50(5):1040-1048. PubMed ID: 32911281
[TBL] [Abstract][Full Text] [Related]
57. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
58. Polymyalgia rheumatica and its links with giant cell arteritis.
Charlton R
Clin Med (Lond); 2008 Oct; 8(5):498-501. PubMed ID: 18975481
[TBL] [Abstract][Full Text] [Related]
59. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden.
Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B
Scand J Rheumatol; 2017 Nov; 46(6):484-489. PubMed ID: 28276953
[TBL] [Abstract][Full Text] [Related]
60. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
